Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 63
Filter
1.
Neurology ; 77(20): 1812-8, 2011 Nov 15.
Article in English | MEDLINE | ID: mdl-22013176

ABSTRACT

OBJECTIVE: The clinical features and genetics of Rett syndrome (RTT) have been well studied, but examination of quality of life (QOL) is limited. This study describes the impact of clinical severity on QOL among female children and adolescents with classic RTT. METHODS: Cross-sectional and longitudinal analyses were conducted on data collected from an NIH-sponsored RTT natural history study. More than 200 participants from 5 to 18 years of age with classic RTT finished their 2-year follow-up at the time of analysis. Regression models after adjustment for their MECP2 mutation type and age at enrollment were used to examine the association between clinical status and QOL. RESULTS: Severe clinical impairment was highly associated with poor physical QOL, but worse motor function and earlier age at onset of RTT stereotypies were associated with better psychosocial QOL; conversely, better motor function was associated with poorer psychosocial QOL. CONCLUSIONS: Standard psychosocial QOL assessment for children and adolescents with RTT differs significantly with regard to their motor function severity. As clinical trials in RTT emerge, the Child Health Questionnaire 50 may represent one of the important outcome measures.


Subject(s)
Quality of Life/psychology , Rett Syndrome/physiopathology , Rett Syndrome/psychology , Adolescent , Child , Child, Preschool , Cross-Sectional Studies , Female , Follow-Up Studies , Humans , Methyl-CpG-Binding Protein 2/genetics , Mutation/genetics , Neuropsychological Tests , Severity of Illness Index
2.
Neurology ; 74(11): 909-12, 2010 Mar 16.
Article in English | MEDLINE | ID: mdl-20231667

ABSTRACT

BACKGROUND: Rett syndrome (RTT) is a neurodevelopmental disorder primarily seen in females, most with a mutation in MECP2. Epilepsy has been reported in 50%-80%. Previous reports were based on small sample sizes or parent-completed questionnaires, or failed to consider the impact of specific MECP2 mutations. METHODS: The Rare Disease Consortium Research Network for RTT is an NIH-funded project to characterize the clinical spectrum and natural history of RTT in advance of clinical trials. Evaluations include clinical status (classic vs atypical RTT), MECP2 mutations, clinical severity, and presence, frequency, and treatment of seizures. RESULTS: Enrollment as of June 2008 is 602; 528 (88%) meet clinical criteria for classic RTT. Of these, 493 (93%) have MECP2 mutations. Age range was 8 months to 64 years. A total of 360 (60%) were reported to have seizures, including 315 (60%) classic and 45 (61%) atypical RTT. Physician assessment of the 602 indicated that 48% had seizures. There was no significant difference in seizure occurrence by race/ethnicity. A significant age impact for seizures was seen and seizures were infrequent before age 2 years. MECP2 mutations most frequently associated with epilepsy were T158M (74%) and R106W (78%), and less frequently R255X and R306C (both 49%). Individuals with seizures had greater overall clinical severity, and greater impairment of ambulation, hand use, and communication. DISCUSSION: Seizures are common in Rett syndrome, have an age-related onset and occurrence, vary by mutation, and are associated with greater clinical severity. This information represents a key consideration for designing clinical trials.


Subject(s)
Epilepsy/genetics , Rett Syndrome/genetics , Adolescent , Adult , Age Factors , Age of Onset , Child , Child, Preschool , Epilepsy/complications , Female , Genetic Predisposition to Disease , Humans , Infant , Male , Methyl-CpG-Binding Protein 2/genetics , Middle Aged , Phenotype , Regression Analysis , Rett Syndrome/complications , Severity of Illness Index , Sex Factors , Young Adult
3.
Neurology ; 70(16): 1313-21, 2008 Apr 15.
Article in English | MEDLINE | ID: mdl-18337588

ABSTRACT

OBJECTIVE: To determine if a relationship exists between the clinical features of Rett syndrome, an X-linked dominant neurodevelopmental disorder, and specific mutations in MECP2. METHOD: Cross-sectional study of 245 girls and women with typical Rett syndrome seen between 1990 and 2004 in tertiary academic outpatient specialty clinics and who had complete MECP2 mutation analysis. A structured clinical evaluation was completed for each participant. The results were grouped by MECP2 mutation and compared. RESULTS: Participants with the R133C mutation are less severely affected than those with R168X or large DNA deletions (p < 0.05). Likewise, individuals with the R168X mutation are more severely affected than those with R294X and late carboxy-terminal truncating mutations (p < 0.05). Clinical differences are notable in ambulation, hand use, and language (p < 0.004), three cardinal features of Rett syndrome. Individuals with R168X are less likely to walk (p = 0.008), retain hand use (p = 0.002), or use words (p = 0.001). In contrast, those with carboxy-terminal truncations are more likely to walk (p = 0.007) and use words (p < 0.001). The R306C mutation, previously found to confer milder features, adversely affects only one clinical feature, language (p < 0.05). CONCLUSIONS: Specific mutations in MECP2 confer different severity. These results allow the design of therapies targeted toward the amelioration of expected problems. Furthermore, the distinct effects of MECP2 mutations on clinical severity must be considered in clinical intervention trials.


Subject(s)
Methyl-CpG-Binding Protein 2/genetics , Mutation/genetics , Rett Syndrome/genetics , Rett Syndrome/physiopathology , Severity of Illness Index , Cross-Sectional Studies , Female , Humans , Methyl-CpG-Binding Protein 2/physiology
4.
Clin Pharmacol Ther ; 83(4): 551-8, 2008 Apr.
Article in English | MEDLINE | ID: mdl-17957186

ABSTRACT

The pharmacokinetics of zolpidem was assessed in this open-label, dose-escalation study in children with insomnia. Twenty-one children, seven per age group (2-6, >6 to 12, >12 to 18 years), received a single dose of zolpidem at one of the three dose levels (0.125, 0.25, or 0.50 mg/kg (20 mg maximum dose)). Multiple pharmacokinetic measures were assessed at nine post-dose intervals and pharmacodynamics was assessed by polysomnography and actigraphy. Significant pharmacokinetic effects by dose were observed only as linear increases in maximum concentration (C(max), P<0.001) and area under the plasma concentration-time curve (AUC, P<0.001). Significant pharmacokinetic effects by age group included an increase in AUC (P=0.02), half-life (P=0.04), and mean residence time (P=0.01), whereas total body clearance decreased (P=0.01) and steady-state volume of distribution was variable. Pharmacodynamic measures were independent of the pharmacokinetic estimates. Overall, zolpidem was well tolerated and a pediatric dose of 0.25 mg/kg is recommended for future efficacy studies.


Subject(s)
Hypnotics and Sedatives/administration & dosage , Hypnotics and Sedatives/pharmacokinetics , Pyridines/administration & dosage , Pyridines/pharmacokinetics , Sleep Initiation and Maintenance Disorders/drug therapy , Adolescent , Age Factors , Analysis of Variance , Area Under Curve , Child , Child, Preschool , Drug Administration Schedule , Female , Humans , Hypnotics and Sedatives/adverse effects , Male , Pyridines/adverse effects , Zolpidem
5.
J Med Genet ; 43(6): 512-6, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16183798

ABSTRACT

BACKGROUND: Angelman syndrome (AS) is a neurodevelopmental disorder characterised by severe mental retardation, dysmorphic features, ataxia, seizures, and typical behavioural characteristics, including a happy sociable disposition. AS is caused by maternal deficiency of UBE3A (E6 associated protein ubiquitin protein ligase 3A gene), located in an imprinted region on chromosome 15q11-q13. Although there are four different molecular types of AS, deletions of the 15q11-q13 region account for approximately 70% of the AS patients. These deletions are usually detected by fluorescence in situ hybridisation studies. The deletions can also be subclassified based on their size into class I and class II, with the former being larger and encompassing the latter. METHODS: We studied 22 patients with AS due to microdeletions using a microarray based comparative genomic hybridisation (array CGH) assay to define the deletions and analysed their phenotypic severity, especially expression of the autism phenotype, in order to establish clinical correlations. RESULTS: Overall, children with larger, class I deletions were significantly more likely to meet criteria for autism, had lower cognitive scores, and lower expressive language scores compared with children with smaller, class II deletions. Children with class I deletions also required more medications to control their seizures than did those in the class II group. CONCLUSIONS: There are four known genes (NIPA1, NIPA2, CYFIP1, & GCP5) that are affected by class I but not class II deletions, thus raising the possibility of a role for these genes in autism as well as the development of expressive language skills.


Subject(s)
Angelman Syndrome/diagnosis , Oligonucleotide Array Sequence Analysis/methods , Sequence Deletion , Angelman Syndrome/genetics , Autistic Disorder/diagnosis , Autistic Disorder/genetics , Base Sequence , Child , Child, Preschool , Chromosomes, Human, Pair 15 , Female , Genetic Testing/methods , Genotype , Humans , Infant , Male , Phenotype , Seizures/diagnosis , Seizures/genetics
8.
Brain Dev ; 23 Suppl 1: S127-32, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11738858

ABSTRACT

Rett syndrome is associated with profound mental retardation and motor disability in girls. It has a characteristic clinical phenotype which includes abnormalities of the autonomic nervous system. Feeding impairment and severe constipation are two symptoms of this autonomic dysfunction. Substance P, an important peptide in the autonomic nervous system, is decreased in the cerebrospinal fluid of Rett syndrome. We have demonstrated that substance P immunoreactivity is significantly decreased in Rett syndrome brain-stem and may be related to the autonomic dysfunction. In this study, we have continued the investigation of substance P in the enteric nervous system. We immunohistochemically examined the normal developing bowel in 22 controls (ages, 14 gestational weeks to 31 years) using formalin fixed tissue, with antibodies to substance P, tyrosine hydroxylase and vasoactive intestinal peptide. We compared the immunoreactivity of normal controls with 14 cases of Rett syndrome (ages, 5-41 years) and observed that the expression of substance P, tyrosine hydroxylase and vasoactive intestinal peptide immunoreactivity in the bowel in Rett syndrome was not significantly different from that of controls. This suggests that the feeding impairment and constipation in Rett syndrome relate to dysfunction of the autonomic nervous system originating outside of the bowel, in the brain-stem, as suggested by our previous study.


Subject(s)
Digestive System/innervation , Enteric Nervous System/metabolism , Gastrointestinal Diseases/metabolism , Rett Syndrome/metabolism , Substance P/metabolism , Adolescent , Adult , Aging/metabolism , Catecholamines/genetics , Catecholamines/metabolism , Child , Child, Preschool , Digestive System/physiopathology , Enteric Nervous System/pathology , Enteric Nervous System/physiopathology , Female , Gastrointestinal Diseases/etiology , Gastrointestinal Diseases/pathology , Humans , Immunohistochemistry , Infant , Infant, Newborn , Neurons/metabolism , Neurons/pathology , Rett Syndrome/pathology , Rett Syndrome/physiopathology , Substance P/genetics , Sympathetic Fibers, Postganglionic/metabolism , Sympathetic Fibers, Postganglionic/pathology , Tyrosine 3-Monooxygenase/genetics , Tyrosine 3-Monooxygenase/metabolism , Vasoactive Intestinal Peptide/metabolism
9.
J Med Genet ; 37(6): 428-33, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10851253

ABSTRACT

BACKGROUND: Smith-Magenis syndrome (SMS) is a multiple congenital anomalies/mental retardation syndrome associated with a hemizygous deletion of chromosome 17, band p11.2. Characteristic features include neurobehavioural abnormalities such as aggressive and self-injurious behaviour and significant sleep disturbances. The majority of patients have a common deletion characterised at the molecular level. Physical mapping studies indicate that all patients with the common deletion are haploinsufficient for subunit 3 of the COP9 signalosome (COPS3), which is conserved from plants to humans, and in the plant Arabidopis thaliana regulates gene transcription in response to light. Haploinsufficiency of this gene is hypothesised to be potentially involved in the sleep disturbances seen in these patients. Melatonin is a hormone secreted by the pineal gland. SMS patients are reported to have fewer sleep disturbances when given a night time dose of this sleep inducing hormone. METHODS: Urinary excretion of 6-sulphatoxymelatonin (aMT6s), the major hepatic metabolite of melatonin, in 19 SMS patients were measured in conjunction with 24 hour sleep studies in 28 SMS patients. Five of the 28 patients did not have the common SMS deletion. To investigate a potential correlation of COPS3 haploinsufficiency and disturbed melatonin excretion, we performed fluorescence in situ hybridisation (FISH) using two BACs containing coding exons of COPS3. RESULTS: All SMS patients show significant sleep disturbances when assessed by objective criteria. Abnormalities in the circadian rhythm of aMT6s were observed in all but one SMS patient. Interestingly this patient did not have the common deletion. All patients studied, including the one patient with a normal melatonin rhythm, were haploinsufficient for COPS3. CONCLUSIONS: Our data indicate a disturbed circadian rhythm in melatonin and document the disturbed sleep pattern in Smith-Magenis syndrome. Our findings suggest that the abnormalities in the circadian rhythm of melatonin and altered sleep patterns could be secondary to aberrations in the production, secretion, distribution, or metabolism of melatonin; however, a direct role for COPS3 could not be established.


Subject(s)
Abnormalities, Multiple/metabolism , Circadian Rhythm , Intellectual Disability/metabolism , Melatonin/metabolism , Abnormalities, Multiple/genetics , Abnormalities, Multiple/urine , Adolescent , Adult , COP9 Signalosome Complex , Child , Child, Preschool , Chromosomes, Human, Pair 17/genetics , Exons/genetics , Female , Humans , In Situ Hybridization, Fluorescence , Intellectual Disability/genetics , Intellectual Disability/urine , Male , Melatonin/analogs & derivatives , Melatonin/urine , Multiprotein Complexes , Peptide Hydrolases , Polysomnography , Proteins/genetics , Sequence Deletion/genetics , Sleep, REM/physiology , Syndrome
10.
Pediatr Neurol ; 22(4): 259-66, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10788742

ABSTRACT

Severe autonomic dysfunction occurs in Rett syndrome (RS). Substance P, a tachykinin peptide that localizes to several brain regions, including the autonomic nervous system, is reduced in the cerebrospinal fluid of patients with RS. The anatomic localization and intensity of substance P immunoreactivity and glial fibrillary acidic protein-positive astrocytes in the brains of 14 patients with RS were compared with those in the brains of 10 age-matched normal patients. Substance P immunoreactivity expression was significantly decreased in RS tissue compared with control tissue in the following regions: dorsal horns, intermediolateral column of the spinal cord, spinal trigeminal tract, solitary tract and nucleus, parvocellular and pontine reticular nuclei, and locus ceruleus. A less significant decrease of substance P immunoreactivity occurred in the substantia nigra, central gray of the midbrain, frontal cortex, caudate, putamen, globus pallidus, and thalamus. Antiglial fibrillary acidic protein-positive astrocytes were increased in the areas in which substance P immunoreactivity was decreased and in other brain regions. Because many of the brain regions with the greatest decrease in substance P immunoreactivity are involved in the control of the autonomic nervous system, especially the solitary tracts and reticular formation, reduced substance P may contribute to the autonomic dysfunction in RS.


Subject(s)
Brain Chemistry , Brain/pathology , Rett Syndrome/pathology , Substance P/analysis , Adolescent , Adult , Age Factors , Antibodies , Astrocytes/chemistry , Astrocytes/pathology , Basal Ganglia/chemistry , Basal Ganglia/pathology , Brain Stem/chemistry , Brain Stem/pathology , Child , Female , Frontal Lobe/chemistry , Frontal Lobe/pathology , Glial Fibrillary Acidic Protein/analysis , Glial Fibrillary Acidic Protein/immunology , Hippocampus/chemistry , Hippocampus/pathology , Humans , Mesencephalon/chemistry , Mesencephalon/pathology , Neurons/chemistry , Neurons/pathology , Substance P/immunology , Thalamus/chemistry , Thalamus/pathology
11.
Ann Neurol ; 47(5): 670-9, 2000 May.
Article in English | MEDLINE | ID: mdl-10805343

ABSTRACT

We screened 71 sporadic and 7 familial Rett syndrome (RTT) patients for MECP2 mutations by direct sequencing and determined the pattern of X chromosome inactivation (XCI) in 39 RTT patients. We identified 23 different disease-causing MECP2 mutations in 54 of 71 (76%) sporadic patients and in 2 of 7 (29%) familial cases. We compared electrophysiological findings, cerebrospinal fluid neurochemistry, and 13 clinical characteristics between patients carrying missense mutations and those carrying truncating mutations. Thirty-one of 34 patients (91%) with classic RTT had random XCI. Nonrandom XCI was associated with milder phenotypes, including a mitigated classic RTT caused by a rare early truncating mutation. Patients with truncating mutations have a higher incidence of awake respiratory dysfunction and lower levels of cerebrospinal fluid homovanillic acid. Scoliosis is more common in patients with missense mutations. These data indicate that different MECP2 mutations have similar phenotypic consequences, and random XCI plays an important role in producing the full phenotypic spectrum of classic RTT. The association of early truncating mutations with nonrandom XCI, along with the fact that chimeric mice lacking methyl-CpG-binding protein 2 (MeCP2) function die during embryogenesis, supports the notion that RTT is caused by partial loss of MeCP2 function.


Subject(s)
DNA-Binding Proteins/genetics , Dosage Compensation, Genetic , Gene Expression/genetics , Point Mutation/genetics , Rett Syndrome/genetics , X Chromosome/genetics , DNA Mutational Analysis , Electrophysiology/methods , Humans , Infant , Mutation, Missense/genetics , Pedigree , Phenotype , Severity of Illness Index
12.
J Pediatr Gastroenterol Nutr ; 29(1): 31-7, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10400100

ABSTRACT

BACKGROUND: Feeding impairment frequently complicates the course of children with neurologic disorders and places them at risk for malnutrition and growth failure. Although feeding abnormalities have been reported in female patients with Rett syndrome, the mechanisms that account for these findings have not been elucidated fully. This study was designed to characterize the clinical features of oropharyngeal and gastroesophageal dysfunction and their impact on the dietary intake and nutritional status of female subjects with Rett syndrome. METHODS: The clinical features of oropharyngeal and gastroesophageal dysfunction in 13 female patients with Rett syndrome, (age range, 3.7 to 25.7 years) were characterized by an oral feeding assessment, swallowing function study, and upper gastrointestinal series. Growth, nutritional status, and body composition were determined by stadiometry and anthropometry. Dietary intakes were determined from 3-day food records. RESULTS: Oropharyngeal dysfunction and gastroesophageal dysmotility were present in 100% and 69%, respectively, of the study patients with Rett syndrome. The scope and severity of these abnormalities were apparent only by videofluoroscopy. Abnormalities of oropharyngeal function included poor tongue mobility, reduced oropharyngeal clearance, and laryngeal penetration of liquids and solid food during swallowing. Esophageal dysmotility included absent primary or secondary waves, delayed emptying, atony, the presence of tertiary waves, spasm, and gastroesophageal reflux. Gastric dysmotility included diminished peristalsis or atony. Lower dietary energy intakes were associated with persistence of residue in the valleculae and pyriform sinuses and less body fat. CONCLUSION: The prevalence of oropharyngeal dysfunction and gastroesophageal dysmotility warrants early diagnostic evaluation and intervention strategies to improve the nutritional status of girls and women with RS.


Subject(s)
Esophageal Motility Disorders/physiopathology , Nutritional Status , Oropharynx/physiopathology , Rett Syndrome/physiopathology , Adolescent , Adult , Child , Child, Preschool , Deglutition , Energy Intake , Female , Gastric Emptying , Humans
13.
Pediatr Neurol ; 20(2): 125-9, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10082341

ABSTRACT

Rett syndrome is a disorder of unknown etiology in females that manifests as severe mental and motor retardation during the first years of life. A postnatal pattern of altered growth is its earliest clinical expression. Head growth decelerates during the first year of age and is followed by a decline in somatic (height/weight) growth. The decreased occipitofrontal circumference (OFC) is reflected in decreased brain size, and measurements of the dendrites of cortical neurons suggest that a developmental and growth arrest have occurred. To further document growth in Rett syndrome, measurements of organ weights, as recorded in 39 postmortem examination studies were compared with normal organ weights for females of comparable age and height. These organ weights suggest that the pattern of growth failure in Rett syndrome, as compared with other forms of mental handicap, such as Down syndrome and Turner's syndrome, may be unique. In Rett syndrome the rate of brain growth, as derived from OFC, decelerates after birth. The increment in normal brain weight after 4 years of age, the age of the first postmortem examinations, is not observed in the Rett brain. The heart, kidneys, liver, and spleen grow at the normally defined rate until 8-12 years of age, when their growth rate decelerates, but their growth continues achieving organ weights that are appropriate for the height of the female. Adrenal weights are normal. These observations suggest that despite a generalized decreased growth in Rett syndrome the brain may be preferentially affected in this syndrome.


Subject(s)
Growth Disorders/pathology , Rett Syndrome/pathology , Adolescent , Adult , Age Factors , Body Height , Brain/growth & development , Brain/pathology , Case-Control Studies , Child , Child, Preschool , Disease Progression , Female , Growth Disorders/etiology , Growth Disorders/physiopathology , Heart/growth & development , Humans , Kidney/growth & development , Kidney/pathology , Liver/growth & development , Liver/pathology , Reference Values , Rett Syndrome/complications , Rett Syndrome/physiopathology , Spleen/growth & development , Spleen/pathology
14.
Seizure ; 8(8): 439-40, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10628963

ABSTRACT

Epilepsy is a complex, common disorder with severe consequences for patients. The authors believe that a significant percentage of patients are receiving suboptimal care. The national standard of care needs to be upgraded to include the notion that patients with less than total seizure control or those suffering from any medication side-effects should be given the opportunity to receive specialty care by physicians with specific expertise in the field of epilepsy.


Subject(s)
Epilepsy/therapy , Medicine , Neurology , Quality of Health Care , Specialization , State Medicine/standards , Health Promotion , Humans , United Kingdom
15.
Electroencephalogr Clin Neurophysiol ; 106(1): 79-83, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9680167

ABSTRACT

Epileptic seizures are reported to occur frequently in Rett syndrome (RS). We evaluated the hypothesis that many events classified as seizures in RS represent other paroxysmal, non-epileptic events; thus, the overall incidence of seizures in RS is overestimated. We conducted video/polygraphic/EEG monitoring sessions (8-120 h duration) in 82 RS females (ages 2-30 years). Fifty-five patients (67%) had a history of seizures and 43 (52%) were receiving anticonvulsants. All had abnormal EEGs. These abnormalities included epileptiform findings, the frequency of which ranged from 60% of patients in clinical stage IV to 97% of patients in clinical stage III. During monitoring, electrographic seizures were recorded in only 13 patients (16%) and included both partial and generalized events. Clinical events correlating with EEG seizure discharges were identified by parents during only 5 of these recordings. The parents of 23 (42%) of the 55 patients with a history of seizures identified events during monitoring that they felt were representative of the child's typical 'seizures', but which were not associated with EEG seizure discharges. These 'non-seizure' events included episodes of motor activity, such as twitching, jerking, head turning, falling forward, and trembling, as well as episodes of staring, laughing, pupil dilatation, breath holding and hyperventilation. These studies confirm that the occurrence of epileptic seizures is overestimated in RS, and further suggest that actual seizures may be under-recognized. Video/EEG monitoring can provide definitive information regarding the need for anticonvulsant therapy in RS.


Subject(s)
Rett Syndrome/complications , Rett Syndrome/physiopathology , Seizures/etiology , Seizures/physiopathology , Adolescent , Adult , Anticonvulsants/therapeutic use , Child , Child, Preschool , Electroencephalography , Female , Humans , Seizures/drug therapy , Television
16.
J Child Neurol ; 13(2): 71-4, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9512306

ABSTRACT

Growth failure is a major aspect of the developmental arrest in Rett syndrome. Small hands and feet have been reported anecdotally, but the pattern of hand and foot growth has not been studied rigorously. The aims of this study were to characterize the hand and foot growth of 28 girls with Rett syndrome and to examine the relationship between their hand or foot size and height. Median hand length deviated to the 5th percentile at 11 years of age whereas median foot length and height deviated below the 5th percentile at 5.5 years of age. After adjusting for height-age, a greater proportion of foot lengths than hand lengths was less than the 50th percentile. In conclusion, the rate of hand and foot growth of girls with Rett syndrome is slower than that of the normal female. Moreover, the rate of deceleration of foot, but not hand, growth relative to height growth is greater. Thus, many girls with Rett syndrome have "small" feet, but not hands, for their height.


Subject(s)
Foot/growth & development , Hand/growth & development , Rett Syndrome/physiopathology , Adolescent , Age Factors , Anthropometry , Child , Child, Preschool , Female , Foot/pathology , Hand/pathology , Humans
17.
J Pediatr ; 132(2): 228-33, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9506632

ABSTRACT

OBJECTIVE: To determine whether increased total daily energy expenditure (TDEE) associated with repetitive, involuntary movements contributes to growth failure in girls with Rett syndrome (RS). STUDY DESIGN: Fourteen girls with RS and 11 healthy girls were studied for 10 days to obtain measurements of height, weight, body circumference, and skin-fold thickness with stadiometric and anthropometric methods; whole-body potassium by potassium 40 counting; 72-hour dietary energy intakes by test weighing; 24-hour activity patterns using observational methods; and TDEE using the doubly-labeled water technique. RESULTS: TDEE, when adjusted for differences in lean body mass, did not differ significantly between girls with RS and healthy girls. Although girls with RS spent more waking hours in physical activity than their healthy counterparts (85%+/-10% vs. 73%+/-11% awake time per day, p < 0.05), their repetitive movements were not sufficiently intense to increase TDEE. However, girls with RS had significantly less lean body mass, but not body fat, which contributed to their lower absolute TDEE in comparison with that of healthy girls (845+/-251 vs. 1453+/-534 kcal/day, p < 0.01). Dietary energy intake, when adjusted for differences in body weight, was not significantly different in girls with RS compared with healthy girls. CONCLUSIONS: Increased TDEE as a result of repetitive, involuntary movements does not explain the alterations in growth and body composition of girls with RS.


Subject(s)
Energy Metabolism , Growth Disorders/physiopathology , Rett Syndrome/physiopathology , Adolescent , Body Mass Index , Child , Child, Preschool , Female , Growth Disorders/etiology , Growth Disorders/metabolism , Humans , Movement Disorders/complications , Rett Syndrome/complications , Rett Syndrome/metabolism
18.
Am J Med Genet ; 62(3): 247-54, 1996 Mar 29.
Article in English | MEDLINE | ID: mdl-8882782

ABSTRACT

Smith-Magenis syndrome (SMS) is a multiple congenital anomaly, mental retardation (MCA/MR) syndrome associated with deletion of chromosome 17 band p11.2. As part of a multi-disciplinary clinical, cytogenetic, and molecular approach to SMS, detailed clinical studies including radiographic, neurologic, developmental, ophthalmologic, otolaryngologic, and audiologic evaluations were performed on 27 SMS patients. Significant findings include otolaryngologic abnormalities in 94%, eye abnormalities in 85%, sleep abnormalities (especially reduced REM sleep) in 75%, hearing impairment in 68% (approximately 65% conductive and 35% sensorineural), scoliosis in 65%, brain abnormalities (predominantly ventriculomegaly) in 52%, cardiac abnormalities in at least 37%, renal anomalies (especially duplication of the collecting system) in 35%, low thyroxine levels in 29%, low immunoglobulin levels in 23%, and forearm abnormalities in 16%. The measured IQ ranged between 20-78, most patients falling in the moderate range of mental retardation at 40-54, although several patients scored in the mild or borderline range. The frequency of these many abnormalities in SMS suggests that patients should be evaluated thoroughly for associated complications both at the time of diagnosis and at least annually thereafter.


Subject(s)
Abnormalities, Multiple/physiopathology , Abnormalities, Multiple/blood , Abnormalities, Multiple/genetics , Adolescent , Adult , Audiometry , Child , Child, Preschool , Chromosome Deletion , Chromosomes, Human, Pair 17 , Eye Abnormalities , Female , Humans , Infant , Male , Neurologic Examination
19.
J Clin Epidemiol ; 48(8): 1069-76, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7775994

ABSTRACT

Few registries are available for evaluating population differences for rare, newly, or ill-defined pediatric neurologic disorders. The purpose of this article is to present standard methodologies for establishing a population-based registry and evaluating the completeness of a registry's case ascertainment. The Texas Rett Syndrome Registry (TRSR) is used as a model. The combination of health care and education resources has identified approx. 89-100% of the Rett syndrome cases in Texas. Cases reported by non-physician sources, although older on average (10.7 vs 7.7 years of age), did not differ by other demographic characteristics from those reported by physicians. Non-physician health and education professionals participated with the TRSR at a significantly higher rate than physicians, 89 and 37% (p < 0.05), respectively. Capture-recapture techniques, both two-sample and log-linear modeling, were used to quantitatively evaluate case ascertainment. Standardized national and international population-based registries could be the basis of an initiative to identify the etiology and perhaps preventive measures for pediatric neurologic disorders.


Subject(s)
Nervous System Diseases/epidemiology , Population Surveillance/methods , Registries , Child , Humans , Linear Models , Models, Statistical , Rett Syndrome/epidemiology , Texas/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...